Nelia Sanchez-Crespo, MD
Internal Medicine · Hollywood, FLNPI 1790990851
Payments from drug & device makers
Across 7,012 payments — averaging $4111.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$9.4M
- Sanofi Pasteur Inc.$7M
- Pfizer$6.8M
- Merck$2M
- Alnylam Pharmaceuticals Inc.$1.4M
- Mylan Technologies Inc.$1.3M
- plus $857K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 5,364 | $9,396,606 |
| Sanofi Pasteur Inc. | 145 | $7,028,421 |
| Pfizer | 169 | $6,801,881 |
| Merck | 20 | $2,049,240 |
| Alnylam Pharmaceuticals Inc. | 1,096 | $1,435,375 |
| Mylan Technologies Inc. | 16 | $1,263,218 |
| Biontech SE | 33 | $489,828 |
| Novavax Inc | 27 | $142,593 |
| Novartis | 6 | $89,017 |
| GSK | 14 | $69,075 |
| Boehringer Ingelheim International GmbH | 5 | $26,412 |
| AbbVie | 3 | $16,469 |
| H. Lundbeck A S | 2 | $14,768 |
| Boehringer Ingelheim Canada Ltd.ltee | 3 | $3,989 |
| Boehringer Ingelheim | 3 | $2,259 |
| Novo Nordisk | 14 | $370 |
| Lilly USA, LLC | 22 | $343 |
| Bayer | 13 | $284 |
| AstraZeneca | 13 | $276 |
| Mylan Inc. | 2 | $251 |
| Johnson & Johnson(2 entities) | 3 | $248 |
| Exact Sciences | 10 | $223 |
| Medical Device Business Services, Inc. | 1 | $122 |
| Hologic Sales And Service, LLC | 3 | $93 |
| Astellas Pharma US Inc | 3 | $88 |
| Eisai Inc. | 5 | $88 |
| Viiv Healthcare Company | 3 | $84 |
| Medtronic | 1 | $65 |
| Merz North America, Inc. | 1 | $65 |
| Abbott | 3 | $50 |
| Dexcom, Inc. | 2 | $45 |
| Shield Therapeutics Inc | 1 | $20 |
| Amgen | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Baxter Healthcare | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
How this compares
$28,831,970 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Hollywood
- Juan Carlos RondonHollywood$66.8M
- Gerard AcloqueHollywood$14.5M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Kwabena AyesuOrlando$27.6M
- Michael DeverWindermere$24M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.